How much funding has LifeMine Therapeutics raised?

LifeMine Therapeutics has raised $300.0M in total funding, most recently a Venture Round.

Who are LifeMine Therapeutics's investors?

LifeMine Therapeutics's investors include WuXi Healthcare Ventures, Fidelity Management, Invus, 3W Partners Capital, GV, ARCH Venture Partners.

When was LifeMine Therapeutics founded?

LifeMine Therapeutics was founded in 2016.

Where is LifeMine Therapeutics headquartered?

LifeMine Therapeutics is headquartered in Cambridge, Massachusetts, United States.

What industry is LifeMine Therapeutics in?

LifeMine Therapeutics operates in Biotech, Drug Discovery, Genomics, Life Sciences.

How many employees does LifeMine Therapeutics have?

LifeMine Therapeutics has 51-200 employees.

LifeMine Therapeutics

Next-generation precision medicines from fungal evolution

Cambridge, United States · Founded 2016 · $300.0M raised

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: lifeminetherapeutics.com
Total Funding: $300.0M
Last Round: $5.0M Venture RoundJan 2025
Rounds: 5

About

LifeMine Therapeutics is a clinical-stage biopharmaceutical company pioneering Top-Down Drug Discovery™, a bold new approach that leverages evolutionary insights from fungi to unearth next-generation precision medicines. Founded in 2016, LifeMine is the first biotechnology company exploiting the unique ability of fungi to produce powerful drugs optimized through billions of years of evolution. Its data-immersive platform integrates human genetics and genomics, bioinformatics, machine learning, and synthetic biology to deeply mine fungal genomes for genetically encoded small molecules (GEMs). The company's lead program, LIFE-001, is advancing for the treatment of multiple immune-mediated disorders and organ transplant rejection. LifeMine's distinguished team includes co-founders Dr. Gregory Verdine (President & CEO), WeiQing Zhou (COO), and Dr. Richard Klausner (Chairman), with backing from GV and other leading life sciences investors.

Summary

LifeMine Therapeutics is a Biotech company based in Cambridge, United States, founded in 2016. It has raised $300.0M in total across 5 rounds, most recently a $5.0M Venture Round round in Jan 2025. Investors include WuXi Healthcare Ventures, Fidelity Management and Invus.

LinkedIn GitHub